Imipenem

CAS 74431-23-5 5 current records 3 historicalSmall Molecule

Who holds supplier records for Imipenem? 5 organisations hold a current record for Imipenem: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), China (1), Italy (1) and Poland (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Imipenem: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/imipenem

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Imipenem. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Shandong Anhong Pharmaceutical Co., Ltd.
    Active DMF 41733 · latest filing May 2025
    ChinaCEP Company GMP cert on record
  • ACS DOBFAR SPA
    Active DMF 21535 · latest filing Apr 2008
    Italy Company GMP cert on record
  • HIGH SCIENCE CO LTD
    Active DMF 31777 · latest filing Aug 2017
    Poland
  • UNIMARK REMEDIES LTD
    Active DMF 28356 · latest filing Jun 2014
    India
  • Sun Pharmaceutical Industries Limited
    Inactive DMF 20086 · latest filing Dec 2006
    IndiaCEP Company GMP cert on record
Need Imipenem sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Imipenem, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2024-396 - Rev 00
Imipenem monohydrate, Sterile, Synthetic origin
Oct 2025Inspected Nov 2025
Greece
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2008-325 - Rev 04
Imipenem monohydrate, Sterile
Apr 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Imipenem are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • AURONEXT PHARMA PRIVATE LTD
    Inactive DMF 28802 · filed Dec 2014
  • PFIZER HEALTHCARE INDIA PVT LTD
    Inactive DMF 21705 · filed Jul 2008
  • Taiwan · Inactive DMF 19937 · filed Nov 2006

Overview

Imipenem is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL43708).

Chemical identity

IUPAC name
(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;hydrate
Canonical SMILES
C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.O
InChIKey
GSOSVVULSKVSLQ-JJVRHELESA-N
Synonyms
Imipemide, Imipenem, Imipenem component of primaxin, Imipenem component of recarbrio, Imipenem hydrate, Imipenem monohydrate, Imipenem monohydrate (h2o), MK-0787, NSC-759901, IMIPENEM MONOHYDRATE [MI], IMIPENEM MONOHYDRATE [WHO-DD], RefChem:790834

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Imipenem?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Imipenem: Shandong Anhong Pharmaceutical Co., Ltd. (China), ACS DOBFAR SPA (Italy), HIGH SCIENCE CO LTD (Poland), UNIMARK REMEDIES LTD (India) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Imipenem Drug Master Files are active?

Shandong Anhong Pharmaceutical Co., Ltd. (DMF 41733), ACS DOBFAR SPA (DMF 21535), HIGH SCIENCE CO LTD (DMF 31777) and UNIMARK REMEDIES LTD (DMF 28356). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Imipenem records mean?

3 organisations have only inactive Type II DMFs for Imipenem. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Imipenem have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Imipenem on the EDQM register, including SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou (CN) and SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Imipenem supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Imipenem?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.